(Q40423520)

20 September 2017

1 reference

title

Molecular basis for heterogeneity in human neuroblastomas (English)

1 reference

20 September 2017

1 reference

G. M. Brodeur

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7576954

19 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7576954

19 May 2024

publication date

1 January 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:095980499500040P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

https://api.elsevier.com/content/article/PII:095980499500040P?httpAccept=text/plain

19 May 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

European Journal of Cancer

19 May 2024

published in

1 reference

20 September 2017

volume

31A

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

505-510

1 reference

Molecular biology and genetics of human neuroblastoma

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Neuroblastoma--clinical applications of molecular parameters

19 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Neuroblastoma. Effect of genetic factors on prognosis and treatment

19 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Molecular basis of clinical heterogeneity in neuroblastoma

19 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Mutation and cancer: neuroblastoma and pheochromocytoma

19 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Developmental Genetics of Neuroblastoma12

19 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Monozygotic siblings discordant for neuroblastoma: etiologic implications

19 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Familial neuroblastoma. Case reports, literature review, and etiologic considerations

19 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Molecular biology and genetics of human neuroblastoma

19 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma

19 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Tumour karyotype may be important in the prognosis of human neuroblastoma

19 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Chromosome findings and prognosis in neuroblastoma

19 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Different karyotypic patterns in early and advanced stage neuroblastomas

19 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma

19 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening

19 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

19 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome

19 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10-year retrospective study

19 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis

19 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

19 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Chromosomal aberrations in human neuroblastomas

19 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Neuroblastoma consensus deletion maps to 1p36.1-2.

19 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Use of the single‐strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma

19 May 2024

36

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Characterization of the region of consistent deletion within 1p36 in neuroblastomas

19 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma

19 May 2024

39

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Two distinct deleted regions on the short arm of chromosome I in neuroblastoma

19 May 2024

40

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines

19 May 2024

41

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Frequent loss of heterozygosity on chromosome 14q in neuroblastoma

19 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas

19 May 2024

45

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Deletion mapping of chromosomes 14q and 1p in human neuroblastoma

19 May 2024

46

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Deletion of chromosome 11 and of 14q sequences in neuroblastoma

19 May 2024

47

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

19 May 2024

48

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Transposition and amplification of oncogene-related sequences in human neuroblastomas

19 May 2024

49

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Specific DNA sequence amplification in human neuroblastoma cells

19 May 2024

50

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc

19 May 2024

51

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Gene amplification in human neuroblastomas: basic mechanisms and clinical implications

19 May 2024

52

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA.

19 May 2024

53

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma

19 May 2024

54

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

19 May 2024

55

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

19 May 2024

56

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Clinical implications of oncogene activation in human neuroblastomas

19 May 2024

57

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene

19 May 2024

58

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients

19 May 2024

60

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.

19 May 2024

61

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Amplification and expression of the N-myc gene in neuroblastoma

19 May 2024

63

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

N-myc oncogene RNA expression in neuroblastoma

19 May 2024

64

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

myc gene amplification and expression in primary human neuroblastoma

19 May 2024

65

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Inverse relationship between trk expression and N-myc amplification in human neuroblastomas

19 May 2024

66

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification

19 May 2024

67

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line

19 May 2024

68

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Structure and activation of the human N-ras gene

19 May 2024

69

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Incidence of ras gene mutations in neuroblastoma

19 May 2024

70

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Activated N-ras oncogenes in human neuroblastoma

19 May 2024

71

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis

19 May 2024

73

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases

19 May 2024

74

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor

19 May 2024

75

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor

19 May 2024

76

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

The trk proto-oncogene encodes a receptor for nerve growth factor

19 May 2024

77

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3

19 May 2024

78

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3

19 May 2024

79

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor

19 May 2024

80

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity

19 May 2024

81

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

19 May 2024

82

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

19 May 2024

83

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis

19 May 2024

84

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages

19 May 2024

85

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Expression and function of TRK-B and BDNF in human neuroblastomas

19 May 2024

86

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS

19 May 2024

87

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

The natural history of neuroblastic cells in the fetal adrenal gland

19 May 2024

88

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal

19 May 2024

89

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study

19 May 2024

90

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children

19 May 2024

91

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

19 May 2024

92

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00040-P

19 May 2024

Identifiers

1 reference

20 September 2017

1 reference